The India Advantage
 
India is the preferred location for conducting clinical trials and stands on a firm platform to showcase the capabilities for global clinical trials needs. Some of the major highlights are:
 
Huge population of approx 1.2 billion providing a wide ranges of indications and satisfactory figure for any clinical trial sample size
Inherent advantages like ethnically diverse and a large pool of treatment naïve patient population
700,000 specialty hospital beds
221 medical colleges
Highly skilled English-speaking and well trained medical personnel
Rapid patient recruitment and timely completion of projects.
The relative cost savings for 30%-50%
It is predicted that Indian Clinical Trials market revenue would grow more than $1 billion and India will be conducting more than 18 percent of total global clinical trials by 2012.
Government’s initiative to regulate CROs, investigators and pharmaceutical companies directly and acceptance of the International Conference on Harmonization (ICH) guideline for good clinical practices
Comprehensive source data storage, in English, by almost all hospitals/ medical or research centers
 
HOME  |   CONTACT US  |   SITEMAP  |   DISCLAIMER ©2010 ICBIO CLINICAL RESEARCH PVT.LTD. ALL RIGHTS RESERVED.